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Xenopus oocytes arrested in prophase I resume meiotic division in response to progesterone and arrest at metaphase II.
ntry into meiosis I depends on the activation of Cdc2 kinase [M-phase promoting factor (MPF)]. To better understand the
ole of Cdc2, MPF activity was specifically inhibited by injection of the CDK inhibitor, Cip1. When Cip1 is injected at
erminal vesicle breakdown (GVBD) time, Cdc25 and Plx1 are both dephosphorylated and Cdc2 is rephosphorylated on
yrosine. The autoamplification loop characterizing MPF is therefore not only required for MPF generation before GVBD,
ut also for its stability during the GVBD period. The ubiquitine ligase anaphase-promoting complex/cyclosome (APC/C),
esponsible for cyclin degradation, is also under the control of Cdc2; therefore, Cdc2 activity itself induces its own
nactivation through cyclin degradation, allowing the exit from the first meiotic division. In contrast, cyclin accumulation,
esponsible for Cdc2 activity increase allowing entry into metaphase II, is independent of Cdc2. The c-Mos/mitogen-
ctivated protein kinase (MAPK) pathway remains active when Cdc2 activity is inhibited at GVBD time. This pathway
ould be responsible for the sustained cyclin neosynthesis. In contrast, during the metaphase II block, the c-Mos/MAPK
athway depends on Cdc2. Therefore, the metaphase II block depends on a dynamic interplay between MPF and CSF, the
-Mos/MAPK pathway stabilizing cyclin B, whereas in turn, MPF prevents c-Mos degradation.
Key Words: Xenopus oocyte; c-Mos; Cdc2; cyclins; meiotic maturation.INTRODUCTION
Two protein kinases play a pivotal role during the oocyte
meiotic maturation in all studied animal species: the
M-phase promoting factor (MPF),2 a complex of Cdc2 kinase
and cyclin B, and mitogen-activated protein kinase (MAPK)
(Gebauer and Richter, 1997; Jessus and Ozon, 1993). De-
pending on the species, both kinases, that are activated
with various time courses, are connected to each other by
different molecular cross-talks. Surprisingly, the MAPK
pathway appears to be differentially involved at different
steps of the meiotic maturation process. It is therefore of
crucial interest to clarify the interplays between Cdc2
1 To whom correspondence should be addressed. Fax: (33) 1 44 27
34 72. E-mail: jessus@ccr.jussieu.fr.
2 Abbreviations: GVBD, germinal vesicle breakdown; MAPK,
itogen-activated protein kinase; MPF, M-phase promoting factor;
PC, anaphase-promoting complex; APC/C, APC/cyclosome.
0012-1606/01 $35.00kinase and the MAPK pathway during this biological pro-
cess.
In Xenopus, oocyte maturation is triggered by progester-
one. This cellular process allows resting oocytes, arrested at
the first meiotic prophase, to resume the first meiotic
division and to arrest at metaphase II. The meiotic matura-
tion period can be divided into three phases (for review, see
Ferrell, 1999): (1) A pre-GVBD period, starting after hor-
monal addition and lasting between 3 and 5 h until GVBD;
(2) The metaphase I/metaphase II transition, or interkinesis.
Nuclear envelopes do not reform, chromosomes remain
condensed, and DNA replication does not occur; (3) The
metaphase II arrest.
During the pre-GVBD period, Cdc2 and MAPK turn on at
about the same time, just before GVBD (Ferrell et al., 1991;
Gotoh et al., 1995; Jessus et al., 1991; Nebreda and Hunt,
1993). MPF is activated by the Cdc25 phosphatase, which
removes the inhibitory phosphates on Thr14 and Tyr15 of
Cdc2. MAPK activation depends on the c-Mos protein
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280 Frank-Vaillant et al.accumulation. c-Mos protein kinase is an efficient activator
of MAPK kinase, that in turn activates MAPK (Nebreda
and Hunt, 1993; Posada et al., 1993). How are the Cdc2
pathway and the MAPK pathway connected? c-Mos synthe-
sis is required for Cdc2 activation (Sagata et al., 1988),
leading to the conclusion that MPF activation depends on
the MAPK pathway (Gotoh et al., 1991, 1995; Posada et al.,
993). Conversely, inhibition of Cdc2 kinase activation by
ifferent specific proteins prevents c-Mos accumulation
nd MAPK activation, leading to the opposite hypothesis
Frank-Vaillant et al., 1999; Nebreda et al., 1995). Moreover,
he inhibition of MAPK activation does not prevent Cdc2
ctivation induced by progesterone, although the extent of
dc2 kinase activity is lowered, GVBD induction is de-
ayed, and oocytes do not complete meiosis normally in the
bsence of MAPK activity (Fisher et al., 1999; Gross et al.,
000). It is therefore probable that progesterone initiates the
rocess of Cdc2 activation independently of MAPK. Cdc2
inase would stabilize c-Mos, leading to MAPK activation,
hich in turn participates to the full activation of Cdc2.
Soon after GVBD, MPF activity falls during the meta-
hase I/anaphase I transition, due to partial cyclin degrada-
ion, and then rises again leading to entry into meiosis II.
hat does control cyclin degradation and cyclin neosynthe-
is during interkinesis? It is established that inactivating
dc2 kinase during this period leads to the rephosphoryla-
ion of Cdc2 on Tyr15 and reentry into an interphase-DNA-
eplicating state (Furuno et al., 1994; Jessus et al., 1991).
he reincrease in MPF activity is therefore crucial to enter
he second meiotic division and to avoid an interphase state
etween both meiotic divisions. This increase is attributed
o a sustained cyclin neosynthesis (Thibier et al., 1997).
c-Mos is also subjected to an active turnover at GVBD time,
although the level of the protein is stable during the
metaphase I–metaphase II transition (Nishizawa et al.,
1992). Indeed, addition of protein synthesis inhibitors at
GVBD time leads to the disappearance of c-Mos and cyclins,
and consequently to the inactivation of Cdc2 and MAPK
(Nishizawa et al., 1992; Thibier et al., 1997). How are the
Cdc2 pathway and the MAPK pathway connected during
interkinesis? It has been proposed that Cdc2 reactivation
just before metaphase II requires c-Mos function (Furuno et
al., 1994). However, it is not known whether MAPK re-
quires Cdc2 function during the metaphase I–metaphase II
transition. It is also not known to what extent Cdc2 does
control cyclin degradation and cyclin accumulation during
this period.
During the metaphase II arrest, c-Mos protein is stabi-
lized. Inhibition of protein synthesis neither affects the
level of c-Mos protein nor MAPK activity (Nishizawa et al.,
1992; Thibier et al., 1997). In the presence of protein
synthesis inhibitors, MPF activity is stable, although the
cyclin B level is slightly decreased (Thibier et al., 1997).
This shows that the majority of cyclin proteins are stabi-
lized, as explained by the presence of the CSF activity,
initially described by Masui and Markert (1971). The cyto-
static function of the c-Mos/MAPK pathway during the
Copyright © 2001 by Academic Press. All rightmetaphase II arrest is well established (Sagata, 1997). How-
ever, the molecular connection between MAPK and the
ubiquitine ligase, APC/C, responsible for cyclin degrada-
tion (Hershko et al., 1994; King et al., 1995; Sudakin et al.,
1995), is not yet known. It is also not known whether the
MAPK pathway requires Cdc2 function during the meta-
phase II arrest.
Fertilization induces the release of the metaphase II
arrest. The egg–sperm fusion leads to an intracellular in-
crease of calcium concentration, assumed to activate the
Ca21-calmodulin kinase II, that subsequently directs cyclin
degradation via the ubiquitination and proteasome pathway
(Glotzer et al., 1991; Lorca et al., 1993; Murray et al., 1989).
hile cyclin degradation is achieved within 10 min after
he Ca21 wave, c-Mos is degraded later, between 30 and 60
min after oocyte activation, and MAPK is subsequently
inactivated (Lorca et al., 1991; Watanabe et al., 1991). It is
therefore clear that MPF inactivation is not induced by the
disappearance of c-Mos. The CSF activity, attributed to the
MAPK pathway, and more recently to the MAPK substrate
p90rsk (Bhatt and Ferrell, 1999; Gross et al., 1999), is by-
assed by the Ca21 surge that promotes cyclin degradation
espite the presence of c-Mos and active MAPK. It can be
ypothesized that c-Mos degradation is driven by MPF
nactivation.
Therefore, during these different phases of the meiotic
ivisions, a dynamic cross-talk exists between Cdc2 and the
APK pathway. In order to better understand how the
ctivities of both kinases are linked, we investigated the
onsequences of the specific in ovo Cdc2 inhibition. We
ave recently reported that, when injected into prophase
ocytes, the CDK inhibitor Cip1 binds endogenous Cdc2-
yclin B complexes and prevents their activation normally
nduced by progesterone (Frank-Vaillant et al., 1999, 2000).
e demonstrate here that Cip1 is also able to inhibit the
ctive form of Cdc2 present at both GVBD time and
etaphase II. This allowed us to study the role of this
inase from GVBD to metaphase II.
MATERIALS AND METHODS
Materials
Xenopus laevis adult females (CNRS, Rennes, France) were bred
and maintained under laboratory conditions. g[32P]ATP was pur-
chased from Dupont NEN (Boston, MA). Reagents, unless other-
wise specified, were from Sigma (Saint Quentin Fallavier, France).
Recombinant GST-p21cip1 was expressed and purified as described
y Frank-Vaillant et al. (1999).
Xenopus Oocyte Treatment
Fully grown Xenopus oocytes were isolated and prepared as
described (Jessus et al., 1987). For injections at GVBD time, 500
oocytes were incubated in the presence of 1 mM progesterone.
Oocytes were referred as to germinal vesicle breakdown stage when
the first pigment rearrangement appeared; at this stage, they were
collected by groups of 10, injected or not with GST-p21cip1 at 1 mM
s of reproduction in any form reserved.
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281Cdc2 and c-Mos/MAPK Interplay in Xenopus Oocyteintracellular concentration, and immediately incubated or not in
the presence of 100 mg/ml cycloheximide. Extracts were then
prepared at different times following the injection. For injections at
metaphase II, oocytes were incubated in the presence of 1 mM
rogesterone until metaphase II, i.e., 3 h after GVBD. Then meta-
hase II-arrested oocytes were incubated in the presence of 50 mM
GTA for 1 h, before GST-p21cip1 microinjection. Oocytes were
collected 1 or 2 h after the injection. In some cases, control oocytes
and GST-p21cip1-microinjected oocytes were extensively washed
and then activated or not by electric shock, as previously described
(Karsenti et al., 1984). Oocytes were collected 1 h later.
Xenopus Oocyte Extracts
Oocytes were lysed at 4°C in 4 volumes of extraction buffer (EB:
80 mM b-glycerophosphate pH 7.3, 20 mM EGTA, 15 mM MgCl2,
1 mM dithiothreitol, and protease inhibitors: 25 mg/ml leupeptin
and aprotinin, 10 mg/ml pepstatin, 1 mM benzamidine, 1 mM
AEBSF from Pentapharm AG, Basel, Switzerland). To visualize the
electrophoretic shift of Cdc25, 1 mM orthovanadate was included
in EB. Lysates were centrifuged at 15,000g at 4°C for 15 min (Sigma
302K centrifuge). The supernatant was collected and analyzed.
Histone H1 Kinase Assays
Extracts (15 ml; i.e., equivalent of three oocytes) were collected
for p13suc1 binding followed by histone H1 kinase assay in the
resence of g[32P]ATP (Dupont NEN) according to Jessus et al.
1991).
Immunoblotting
Extracts in Laemmli buffer (Laemmli, 1970) equivalent to three
oocytes were loaded on each lane, electrophoresed on 12.5%
SDS–PAGE Anderson gels (Anderson et al., 1973), and transferred
to nitrocellulose filters (Schleicher and Schull, Ecquevilly, France)
using a semi-dry blotting system (Millipore, Saint Quentin, France)
as described in Jessus et al. (1991). The proteins of interest were
visualized by use of the appropriate primary antibody; the follow-
ing antibodies were used: sheep polyclonal anti-cyclin B2 antibody
(Gautier et al., 1990), sheep polyclonal anti-cyclin B1 antibody
(Gautier et al., 1990), mouse anti-Cdc27 antibody (Transduction
Laboratories, Montluc¸on, France), rabbit polyclonal anti-Cdc2
phosphorylated on tyrosine antibody (New England Biolabs, Saint
Quentin, France), rabbit polyclonal anti-Cdc25 antibody (Izumi et
al., 1992), rabbit polyclonal anti-Plx1 antibody (Abrieu et al., 1998),
rabbit polyclonal anti-c-Mos antibody (Santa Cruz Biotechnolo-
gies), and mouse anti-phosphorylated MAPK antibody (New Eng-
land Biolabs). The secondary antibodies were HRP-conjugated
(Jackson Immunoresearch, West Grove, PA). The chemolumines-
cence reagent was from NEN.
RESULTS
Microinjection of Cip1 at GVBD Inhibits MPF
Activity
Cip1 protein is a broad-spectrum inhibitor of cdk/cyclin
complexes (Xiong et al., 1993). When injected into
prophase-arrested oocytes, recombinant human GST-
p21Cip1 prevents MPF activation and GVBD normally in-
Copyright © 2001 by Academic Press. All rightuced by progesterone by direct binding to Cdc2/cyclin B
omplexes (Frank-Vaillant et al., 1999). To better under-
tand the role of Cdc2 during the metaphase I–metaphase II
ransition, we attempted to inhibit MPF activity at GVBD
n order to analyze the molecular consequences of MPF
nhibition at this period.
We first examined whether Cip1 was able to inhibit the
ctive form of Cdc2 present in GVBD oocytes. Oocytes were
ncubated in the presence of 1 mM progesterone and GVBD
was monitored by the appearance of a white spot at the animal
pole. At GVBD time, oocytes were injected or not with Cip1 at
1 mM intracellular concentration and collected at different
imes following the injection. The activity of Cdc2 was
ssayed by measuring histone H1 kinase activity (Fig. 1). Cdc2
as inactive in prophase oocytes and was activated at GVBD
ime. As previously reported in control oocytes, MPF activity
ecreased after GVBD when cyclins are degraded and in-
reased again at entry into metaphase II, when cyclins accu-
ulate. In Cip1-injected oocytes, MPF activity sharply de-
reased after injection; 30 min after GVBD, Cdc2 activity level
as reduced by 80% in the presence of Cip1, whereas it was
ecreased by 30% in control oocytes at the same time. Cdc2
ctivity reached the prophase level within 90 min after Cip1
njection and did not reincrease during the following 2 h. This
xperiment shows that injection of Cip1 at GVBD rapidly
eads to the inhibition of MPF activity and prevents its
ubsequent reactivation at metaphase II, which normally
equires cyclin neosynthesis. The inhibition of Cdc2 activity
y Cip1 injection during the metaphase I–metaphase II tran-
ition allowed us to study the role of this kinase during this
eriod.
Cdc2 Controls Cdc25 Phosphatase and Plx1 Kinase
in Metaphase I
Cdc2 is activated at GVBD by dephosphorylation on
FIG. 1. Effect of Cip1 on Cdc2 activity at GVBD time. Oocytes
were collected at GVBD time and injected (E) or not (h) with Cip1.
Histone H1 kinase activity of Cdc2 was measured in prophase
oocytes, at GVBD, and at 30, 45, 60, 90, 120, and 180 min after
GVBD.Tyr15 and Thr14 by the Cdc25 phosphatase (Dunphy and
s of reproduction in any form reserved.
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282 Frank-Vaillant et al.Kumagai, 1991; Gautier et al., 1991). Cdc25 activity is itself
ositively regulated by Cdc2 activity, contributing to the
ositive feedback loop that allows the abrupt activation of
PF just before GVBD. We addressed the question of
hether Cdc25 activity is still under the control of Cdc2
fter the amplification loop has been completed at GVBD,
eading to a full MPF activation. For this purpose, we
xamined whether Cdc25 electrophoretic mobility was
ltered following the inactivation of Cdc2 by Cip1 at
VBD. Oocytes were microinjected with Cip1 at GVBD
ime and collected at different times following the injec-
ion. Oocyte extracts were subjected to Western blot anal-
sis with an anti-Xenopus Cdc25 antibody. At GVBD,
dc25 underwent an electrophoretic mobility shift (Fig. 2),
orresponding to the phosphorylation and the activation of
he protein (Izumi et al., 1992; Kumagai and Dunphy, 1992).
n control oocytes, the Cdc25 phosphorylation level was
table during interkinesis. A slight decrease in Cdc25 phos-
horylation was observed between 90 and 120 min after
VBD (Fig. 2), corresponding to the decreased level of Cdc2
ctivity at this period (Fig. 1). When Cdc2 was inactivated at
VBD time by Cip1 injection, Cdc25 was progressively
ephosphorylated, as shown by the appearance of multiple
obility bands (Fig. 2). It almost reached the prophase level
FIG. 2. Cdc2 inhibition at GVBD time leads to Cdc25 and Plx1
inactivation. Oocytes were collected at GVBD time and injected
(1Cip1) or not (2Cip1) with Cip1. Western blots were performed
with extracts prepared from prophase oocytes (Pro), or from oocytes
taken at various times after GVBD, with an anti-Cdc25 antibody,
an anti-Plx1 antibody, and an anti-phospho-Tyr-Cdc2 (P-tyr Cdc2)
antibody. Arrows indicate the various migration levels of the
indicated proteins.h after injection, not completely returning to its faster
Copyright © 2001 by Academic Press. All rightigrating unphosphorylated form (Fig. 2). This suggests
hat its phosphatase activity was almost turned off, as
upported by the tyrosine phosphorylation level of Cdc2 at
his period (see later, Fig. 2).
Plx1 kinase activity is also required to phosphorylate and
ctivate Cdc25 in Xenopus oocyte (Karaiskou et al., 1999;
Kumagai and Dunphy, 1996). As previously reported (Qian
et al., 1998), Plx1 was activated at GVBD by phosphoryla-
tion, that is visualized by the electrophoretic migration of
the protein as a doublet (Fig. 2). In control oocytes, Plx1
phosphorylation was stable from GVBD to metaphase II
(Fig. 2). In contrast, the inhibition of Cdc2 activity by Cip1
microinjection at GVBD time led to Plx1 dephosphoryla-
tion, completed within 2 h after the injection (Fig. 2). These
results indicate that the phosphorylation and therefore
activation of both Plx1 and Cdc25 require Cdc2 activity
during the metaphase I–metaphase II transition.
Cdc25 and Plx1 inactivation prompted us to analyze the
tyrosine phosphorylation level of Cdc2 following Cip1
injection at GVBD time. Tyrosine phosphorylation of Cdc2
was monitored at different times following the injection by
Western blotting using an antibody directed against the
tyrosine-phosphorylated form of Cdc2. Cdc2, that was
phosphorylated on tyrosine in prophase oocytes, was then
dephosphorylated at GVBD and remained under this de-
phosphorylated form until metaphase II in control oocytes
(Fig. 2). Three hours after Cip1 microinjection at GVBD,
Cdc2 was rephosphorylated on tyrosine, in parallel with
Cdc25 and Plx1 inactivation (Fig. 2).
Cyclin B1 and Cyclin B2 Accumulation Is
Independent of MPF Activity after GVBD
We next addressed the question of whether cyclin B
degradation and accumulation that normally take place
after GVBD are under the control of Cdc2. Cip1 was
injected into GVBD oocytes and Western blots were per-
formed using anti-Xenopus cyclin B1 and anti-Xenopus
cyclin B2 antibodies (Fig. 3). In control oocytes, cyclin B1
was almost undetectable in prophase oocytes and then
accumulated from GVBD to metaphase II (Fig. 3). The
accumulation pattern of cyclin B1 was identical in oocytes
where Cdc2 was inactivated at GVBD time by Cip1 injec-
tion (Fig. 3).
As already reported (for review, Taieb and Jessus, 1997),
cyclin B2 is associated with inactive tyrosine-
phosphorylated Cdc2 in prophase oocytes and this inactive
form migrates as a doublet (Fig. 3). The protein was elec-
trophoretically shifted at GVBD, at time of Cdc2 activation.
It remained under this form until metaphase II in control
oocytes (Fig. 3). As expected, a slight decrease in cyclin B2
level occurred between metaphase I and metaphase II. The
level of cyclin B2 protein appeared to be stable for 3 h in
oocytes that have been injected with Cip1 at GVBD (Fig. 3).
Under these conditions, the electrophoretic mobility of the
protein was progressively accelerated following Cip1 injec-
tion. Three hours after Cip1 injection, cyclin B2 migrated as
s of reproduction in any form reserved.
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283Cdc2 and c-Mos/MAPK Interplay in Xenopus Oocytea doublet, identical to the inactive prophase form of the
protein (Fig. 3). This observation is correlated with the
rephosphorylation of Cdc2 on Tyr15 following Cip1 injec-
tion (Fig. 2). Altogether, these results show that B-type
cyclins accumulation does not depend on Cdc2 activity
during the metaphase I–metaphase II transition.
APC Phosphorylation and Cyclin Degradation Are
under the Control of Cdc2 Activity
in Metaphase I Oocytes
To estimate whether the degradation of B-type cyclins is
controlled by Cdc2, the same experiments as above were
performed in the presence of cycloheximide. Preventing
cyclin neosynthesis allows the visualization of B-type
cyclins degradation. Oocytes were incubated in the pres-
ence of cycloheximide at GVBD time and simultaneously
injected or not with Cip1. Cyclin B1 level rapidly decreased
in the presence or in the absence of Cip1, being totally
degraded within 1 h following GVBD (Fig. 4). The degrada-
tion time course was delayed in the presence of Cip1 (Fig.
4). In the absence of Cip1, cyclin B2 was degraded between
90 min and 2 h following GVBD, therefore slower than
cyclin B1 (Fig. 4). As for cyclin B1, cyclin B2 decrease was
delayed in response to Cip1 injection (Fig. 4). The delay
observed for cyclin B2 degradation was longer than for
cyclin B1, since significant amounts of cyclin B2 were still
detected 3 h after GVBD (Fig. 4). Under these conditions,
i.e., in the absence of protein synthesis, cyclin B2 migrated
as the up-shifted form and not as a doublet. The cyclin B2
doublet observed following Cip1 injection (Fig. 3) therefore
FIG. 3. Effect of Cdc2 inhibition at GVBD time on cyclins
accumulation. GVBD oocytes were injected (1Cip1) or not (2Cip1)
with Cip1. Oocytes were then collected at various times after
GVBD and subjected to Western blot analysis with an anti-cyclin
B1 antibody and an anti-cyclin B2 antibody. Extracts from prophase
oocytes (Pro) were also probed.depends on protein synthesis.
Copyright © 2001 by Academic Press. All rightSince B-type cyclin degradation was affected by Cdc2
nhibition, we analyzed the phosphorylation level of Cdc27,
n APC/C component whose phosphorylation level is
ighly correlated with APC/C activity (King et al., 1995).
estern blot analysis using an anti-Cdc27 antibody re-
ealed that, in control oocytes, Cdc27 underwent a slight
lectrophoretic mobility shift at GVBD and a subsequent
arger shift at time of metaphase II (Fig. 4). In Cip1-
icroinjected oocytes, the slightly shifted form of Cdc27
bserved at GVBD was converted back into a nonphospho-
ylated form within 90 min to 2 h following Cip1 injection
Fig. 4). Moreover, the large shift observed at metaphase II
as totally prevented by Cip1 injection (Fig. 4). These
lectrophoretic mobility changes in Cdc27 strongly suggest
hat APC/C is inactivated in response to Cdc2 inhibition at
VBD. It has been previously reported that APC/C activa-
ion is dependent on Cdc2 (Lahav-Baratz et al., 1995). Our
ata demonstrate, according to the observed dephosphory-
ation of Cdc27 (Fig. 4), that continuation of APC/C activity
ight also depend on Cdc2 during the metaphase
FIG. 4. Effect of Cdc2 inhibition at GVBD time on cyclins
degradation. GVBD oocytes were injected (1Cip1) or not (2Cip1)
with Cip1 in the presence (1CHX) or in the absence (2CHX) of
cycloheximide. Oocytes were then collected at various times after
GVBD and subjected to Western blot analysis with an anti-cyclin
B1 antibody, an anti-cyclin B2 antibody, and an anti-Cdc27 anti-
body. Extracts from prophase oocytes (Pro) were also probed.
s of reproduction in any form reserved.
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284 Frank-Vaillant et al.I–metaphase II transition. The inactivation of APC/C ex-
plains why cyclin B degradation is delayed in the presence
of Cip1 (Fig. 4). The different time course of degradation of
both cyclins, B1 and B2, suggests that APC/C exhibits a
stronger affinity for cyclin B1 than for cyclin B2. Conse-
quently, cyclin B1 is quickly degraded once APC/C is
phosphorylated and therefore activated at GVBD time, and
its proteolysis is almost completed when APC/C is dephos-
phorylated and presumably inactivated in response to Cdc2
downregulation (Figs. 3 and 4). In contrast, when APC/C is
turned off around 60 min after Cdc2 inactivation, cyclin B2
degradation is not yet achieved, and consequently, the
protein is better stabilized than cyclin B1 (Figs. 3 and 4).
Maintenance of the c-Mos/MAPK Pathway Is
Independent of MPF Activity during the
Metaphase I–Metaphase II Transition
We next examined whether the c-Mos/MAPK pathway is
affected by Cip1 microinjection. Oocytes were microin-
jected with Cip1 at GVBD and extracts were subjected to
Western blot analysis using an anti-c-Mos antibody. As
expected, c-Mos was undetectable in prophase oocytes and
was accumulated at GVBD, migrating as a doublet (Fig. 5).
In control oocytes, the protein was detected at a constant
level from GVBD to metaphase II (Fig. 5). Cip1 injection did
not modify the c-Mos protein pattern for at least 3 h, the
protein being detected as in control oocytes. This result
shows that MPF activity does not control c-Mos turnover
during interkinesis. The same oocyte extracts were sub-
jected to Western blot analysis with an antibody raised
against the phosphorylated active form of MAPK (Fig. 5). As
FIG. 5. Effect of Cdc2 inhibition at GVBD time on the c-Mos/
MAPK pathway. Oocytes were collected at GVBD time and in-
jected (1Cip1) or not (2Cip1) with Cip1. Western blots were
performed with extracts prepared from prophase oocytes (Pro), or
from oocytes at various times after GVBD, with an anti-c-Mos
antibody and an anti-phospho-MAPK antibody.expected, active MAPK was not detectable in prophase
Copyright © 2001 by Academic Press. All rightocytes, and the kinase was activated at GVBD time (Fig. 5).
he phosphorylation level of MAPK was then stable during
he metaphase I–metaphase II transition in control oocytes
Fig. 5). In Cip1-injected oocytes, MAPK remained under its
ctive form as in control oocytes. This result shows that
dc2 activity is not required for maintaining the c-Mos/
APK pathway active during interkinesis.
c-Mos Stability Is under the Control of Cdc2 in
Metaphase II Oocytes
We next investigated the consequences of inhibiting
Cdc2 during the metaphase II arrest. We first tested
whether Cip1 is able to inhibit the active form of Cdc2 that
is stabilized by CSF in metaphase II-arrested oocytes. Oo-
cytes were incubated in the presence of progesterone. The
metaphase II stage was reached 2 h after GVBD, according
the cytological criteria described by Huchon et al. (1993)
and Thibier et al. (1997). At that stage, oocytes were
njected with Cip1. Injections were performed in the pres-
nce of 50 mM EGTA in order to prevent oocyte activation.
ne hour later, oocytes were collected and subjected to
istone H1 kinase assay. Injection of Cip1 led to the
nactivation of Cdc2 kinase, which returned to the prophase
evel within 1 h (Fig. 6, lane 4).
Metaphase II-arrested oocytes were electrically activated.
ne hour after, Cdc2 kinase activity level was similarly
ecreased to the prophase level (Fig. 6, lane 3). When
etaphase II oocytes were first injected with Cip1 and then
ubjected 1 h later to an electric shock, the basal level of
dc2 activity was not further reduced (Fig. 6, lane 6).
To ascertain that Cip1 injection did not promote egg
ctivation, the level of cyclin B2 was analyzed by Western
lot. Figure 6 shows that cyclin B2 is not degraded within
he 2 h following Cip1 injection and is progressively con-
erted into a doublet, characteristic of the prophase stage
Fig. 6, lanes 4–5). In contrast, electric activation of meta-
hase II oocytes led to a sharp decrease of cyclin B2 level
Fig. 6, lane 3). These results demonstrate that MPF inhibi-
ion triggered by Cip1 injection in metaphase II oocytes is
ot a result of oocyte activation, but is rather due to the
irect inhibition of Cdc2 by Cip1. When the electric shock
as applied 1 h after Cip1 injection, cyclin B2 was no
urther degraded (Fig. 6, lane 6), indicating that APC/C was
urned off in parallel with Cip1-induced Cdc2 inactivation.
c-Mos protein level was monitored in oocytes where MPF
ctivity had been inactivated by Cip1 injection during the
etaphase II arrest. Western blot using an anti-c-Mos
ntibody shows that c-Mos was degraded within 1 h after
ip1 microinjection, as it is in response to an electric
ctivation (Fig. 6). Therefore, c-Mos stability is dependent
n Cdc2 activity in metaphase II-arrested oocytes, and
-Mos degradation can occur in the absence of any Ca21
influx, a hypothesis recently suggested by Bodart et al.
(1999), by using a nonspecific kinase inhibitor, the purine
analog 6-DMAP. To estimate MAPK activity, a Western
blot was performed with the antibody recognizing the
s of reproduction in any form reserved.
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was inactivated in parallel with c-Mos degradation after
Cip1 injection (Fig. 6).
DISCUSSION
We have previously reported a new experimental ap-
proach using the CDK inhibitor Cip1 to prevent the activa-
tion of pre-MPF normally induced by progesterone in Xe-
nopus oocytes (Frank-Vaillant et al., 1999, 2000). In this
study, Cip1 was injected into Xenopus oocytes either at
GVBD (entry into metaphase I) or at metaphase II arrest, in
an attempt to inhibit active MPF. Our results demonstrate
that Cip1 injection leads to a rapid inhibition of the fully
active Cdc2 kinase, correlated with cyclin stabilization and
rephosphorylation of Cdc2 on Tyr15. It can be concluded
FIG. 6. Effects of Cip1 on Cdc2 activity and the c-Mos/MAPK
athway in metaphase II oocytes. Histone H1 kinase activity assay
nd Western blot analysis using either an anti-cyclin B2 antibody or
n anti-c-Mos antibody or an anti-phospho-MAPK antibody were
erformed on oocytes after the following treatments: (1) prophase
ocytes; (2) metaphase II oocytes; (3) metaphase II treated by an
lectric shock and collected 1 h later; (4) metaphase II oocytes
icroinjected with Cip1 and collected 1 h after the injection; (5)
etaphase II oocytes microinjected with Cip1 and collected 2 h
fter the injection; and (6) metaphase II oocytes microinjected with
ip1, treated by an electric shock 1 h after the injection and
ollected 1 h later.that injection of Cip1 induces direct MPF inactivation,
Copyright © 2001 by Academic Press. All rightwhich leads to the reformation of inactive cyclin B com-
plexes, comparable to the complexes found in prophase.
Using the specific Cip1 inhibitor, we were therefore able to
analyze the consequences of Cdc2 inactivation from GVBD
to metaphase II.
GVBD period. It is well known that the abrupt activa-
tion of MPF that occurs just before GVBD is the result of a
complex autoamplification process (Masui and Markert,
1971), depending on the positive feedback loop between
Cdc2 and Cdc25. Recent reports have established that Plx1
is involved in this process (Abrieu et al., 1998; Karaiskou et
al., 1998, 1999; Kumagai and Dunphy, 1996). Our results
demonstrate that in the whole oocyte after GVBD, Cdc25
and Plx1 are still under the control of Cdc2. Therefore, once
MPF is fully activated at GVBD, the positive feedback loop
remains dynamic and actively sustained by Cdc2 (Fig. 7).
The amplification loop is therefore not only required for the
rapid generation of MPF before GVBD, but also for the
stability of its activity during the short GVBD period.
Metaphase I–metaphase II transition or interkinesis.
During interkinesis, two sets of events are differentially
regulated by Cdc2.
Cdc25, Plx1, APC/C, and cyclin degradation are strictly
dependent upon Cdc2 activity. Therefore, once MPF is
activated at GVBD, it first maintains its own activity
through the positive regulation of Cdc25 and Plx1. The drop
of Cdc2 activity that is then initiated soon after GVBD
could be the consequence of Cdc2 activity itself: by activat-
ing APC/C, it would indirectly promote cyclin degradation
(Fig. 7). This leads to the exit from the first meiotic division.
In contrast, the elevation of the cyclin level and the
c-Mos/MAPK pathway, once switched on at GVBD, be-
comes independent of Cdc2 activity during the metaphase
I/metaphase II transition. As already suggested by previous
reports (Furuno et al., 1994; Gross et al., 2000), the c-Mos/
MAPK pathway could be necessary for cyclin neosynthesis,
inducing a precocious reincrease in Cdc2 activity that
results in the entry into the second meiotic division in the
absence of interphase (Fig. 7).
Metaphase II block. Strikingly, once the metaphase II
block is reached, the c-Mos/MAPK pathway becomes
strictly dependent on Cdc2 activity. It is therefore probable
that c-Mos proteolysis that follows cyclin degradation after
fertilization (Sagata et al., 1989) does not directly depend on
the Ca21 surge and the Ca21-calmoduline kinase II activa-
tion induced by sperm fusion (Lorca et al., 1993), but rather
results from Cdc2 inactivation, as already proposed by
Bodart et al. (1999). It is also highly probable that c-Mos
degradation, although depending on ubiquitination and
proteasome (Ishida et al., 1993; Nishizawa et al., 1993), is
not mediated through APC/C that is rapidly turned off once
Cdc2 is inactivated. It is well established that the c-Mos/
MAPK pathway is one of the essential components of the
CSF activity, implying that MPF is stabilized by this
pathway in metaphase II-arrested oocytes (Gross et al.,
1999; Haccard et al., 1993; Sagata et al., 1989). Interestingly,
we show that in vivo, the c-Mos/MAPK pathway is recip-
s of reproduction in any form reserved.
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other words, the c-Mos/MAPK pathway prevents cyclin B
degradation by APC/proteasome, whereas MPF prevents
c-Mos from being degraded by a specific ubiquitination/
proteasome system (Fig. 7). The metaphase II block is
therefore based not only on CSF activity, but also on an
MPF-CSF feedback loop. The inactivation of any of them
leads to the degradation of the other one. Although the
metaphase II block looks very static at the level of the
protein turnover, it depends on a dynamic interplay be-
tween MPF and CSF, whose molecular basis remains to be
elucidated.
Establishment of the metaphase II arrest. There is a
crucial switch between the entry into metaphase II and the
block into metaphase II (Fig. 7). In both cases, Cdc2 and the
c-Mos/MAPK pathway are active. However, in the case of
metaphase II entry, the c-Mos/MAPK pathway is indepen-
dent of Cdc2 (our results) and CSF activity is not yet
established (Masui and Markert, 1971; Thibier et al., 1997).
In the case of the metaphase II block, the c-Mos/MAPK
pathway requires Cdc2 activity (our results) and CSF is
activated (Masui and Markert, 1971). What does ensure the
transition between both states? One can postulate that
during this essential transition characterizing the verte-
brate oocyte meiotic maturation, the proteolytic machiner-
ies specific of c-Mos and cyclin B are modified, rendering
c-Mos degradation sensitive to Cdc2 and cyclin B degrada-
FIG. 7. Model. MPF is fully activated at GVBD, and the positive
is then activated by Cdc2 and leads to cyclin degradation. In co
c-Mos/MAPK pathway functions independently of Cdc2 and could
into metaphase II. The metaphase II block is characterized by a re
them stabilizing the other one.tion sensitive to the c-Mos/MAPK pathway.
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